Lisa Nettis Power - 10 Nov 2025 Form 4 Insider Report for NEPHROS INC (NEPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2025, 17:00:38 UTC
Prior SEC filing
13 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Edward Peilen as Attorney-in-Fact for Lisa Nettis pursuant to Power of Attorney filed previously.

Key filing fact

Lisa Nettis Power filed Form 4 for NEPHROS INC (NEPH) on 13 Nov 2025.

Key facts

  • This page summarizes Lisa Nettis Power's Form 4 filing for NEPHROS INC (NEPH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 13 Nov 2025, 17:00.

Change

  • Previous filing in this sequence was filed on 13 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002076008 Primary reporting owner

Nettis Lisa Marie

Relationship
Director
Address
C/O NEPHROS, INC., 380 LACKAWANNA PLACE, SOUTH ORANGE
Signature
Edward Peilen as Attorney-in-Fact for Lisa Nettis pursuant to Power of Attorney filed previously.
Signature date
13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH transaction

Common Stock

Award

Transaction value
$0
Shares
+1,622
Change %
Price
$0.000000
Shares after
1,622
Date
10 Nov 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,229
Date
10 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,229
Exercise price
$4.49
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .